Rang	Name	Position
1	Dr. Christopher R. Anzalone Ph.D.	Chairman, CEO & President
2	Mr. Daniel J. Apel	Chief Financial Officer
3	Mr. Patrick O'Brien J.D., PharmD	COO & Secretary
4	Dr. James C. Hamilton M.D., MBA	Chief Medical Officer and Head of R&D
5	Dr. Mark M. Davis Ph.D.	Founder and Founder & Director of Insert Therapeutics Inc & Calando
6	Dr. Tao Pei Ph.D.	Chief Scientific Officer
7	Dr. Vincent Anzalone CFA	Head of Investor Relations & VP
8	Mr. Howard Lovy	Director of Communications
9	Dr. Bruce D. Given M.D.	Chief Medical Scientist
10	Dr. Mark Seefeld	Head of Toxicology & VP

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	12,86%	1,51 Mrd. USD
2	venBio Select Advisor LLC	7,58%	0,89 Mrd. USD
3	FMR Inc	5,14%	0,60 Mrd. USD
4	Vanguard Portfolio Management, LLC	5,06%	0,59 Mrd. USD
5	State Street Corp	4,60%	0,54 Mrd. USD
6	Vanguard Capital Management, LLC	4,27%	0,50 Mrd. USD
7	Geode Capital Management, LLC	3,03%	0,36 Mrd. USD
8	NORGES BANK	2,76%	0,32 Mrd. USD
9	Fred Alger Management, LLC	2,37%	0,28 Mrd. USD
10	Amvescap Plc.	2,32%	0,27 Mrd. USD
11	Vestal Point Capital LP	1,61%	0,19 Mrd. USD
12	Baker Bros Advisors LP	1,41%	0,17 Mrd. USD
13	The Goldman Sachs Group Inc	1,23%	0,14 Mrd. USD
14	Northern Trust Corp	1,17%	0,14 Mrd. USD
15	Siren, L.L.C.	1,14%	0,13 Mrd. USD
16	Deerfield Management Co	1,11%	0,13 Mrd. USD
17	HHG PLC	1,02%	0,12 Mrd. USD
18	First Trust Advisors L.P.	0,96%	0,11 Mrd. USD
19	UBS Group AG	0,95%	0,11 Mrd. USD
20	UBS Asset Mgmt Americas Inc	0,94%	0,11 Mrd. USD